课题基金 / 基金详情

THE COVID 19 SERVICES CATALYZE TRANSLATIONAL RESEARCH FINDINGS INTO PUBLIC HEALTH CHANGES TO ADDRESS THE NOVEL CORONAVIRUS PANDEMIC THROUGH IMPLEMENTA

THE COVID 19 SERVICES CATALYZE TRANSLATIONAL RESEARCH FINDINGS INTO PUBLIC HEALTH CHANGES TO ADDRESS THE NOVEL CORONAVIRUS PANDEMIC THROUGH IMPLEMENTA
COVID 19 服务促进公共卫生变革的转化研究成果，通过实施应对新型冠状病毒大流行
批准号：
10500611
负责人：
LEONARD FREEDMAN
金额：
$61.29万
依托单位：
LEIDOS BIOMEDICAL RESEARCH, INC.
依托单位国家：
美国
项目类别：
财政年份：
2020
资助国家：
美国
项目状态：
已结题
起止时间：
2020-08-31 至 2021-08-30
来源：
https://reporter.nih.gov/project-details/10500611
关键词：
ACE2AddressBiologicalBiological SciencesCOVID-19COVID-19 assayClientContractsCrystallographyLaboratoriesLigandsPeptidesProductionPublic HealthResearch ActivityResearch PersonnelServicesTranslational Researchdiagnostic assayexperiencenovel coronaviruspandemic diseaseprogramsresearch and developmentscale up

项目摘要

项目成果

LEONARD FREEDMAN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Advanced BioScience Laboratories, Inc. (ABL) is a global contract manufacturing organization with experience in biologics R&D, scale-up, and production following current Good Manufacturing Practices (cGMP). ABL partners with our clients to support GMP manufacturing needs. Dr. Wlodawer, Chief of the Macromolecular Crystallography Laboratory with the NCI-Frederick is working on a project, Chimeric ACE2 Peptide Ligand for Diagnostic Assays of SARS-CoV-2, under the Intramural Targeted Anti-Covid19 (ITAC) Program, which provides supplementary support for COVID-19 research activities for intramural investigators
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DCEG- Repository Services for epidemiology studies
  • 批准号：
    10273214
  • 项目类别：
  • 资助金额：
    $275.03万
  • 财政年份：
    2020
  • 负责人：
    LEONARD FREEDMAN
  • 依托单位：
    LEIDOS BIOMEDICAL RESEARCH, INC.
DCEG- Molecular Assays for epidemiology studies
  • 批准号：
    10273216
  • 项目类别：
  • 资助金额：
    $302.89万
  • 财政年份：
    2020
  • 负责人：
    LEONARD FREEDMAN
  • 依托单位：
    LEIDOS BIOMEDICAL RESEARCH, INC.
VENTANA PD-L1 (SP142), a complimentary diagnostic immunohistochemistry (IHC) assay to ascertain tumor PD-L1 status for patients with metastatic urothelial cancer considering treatment with atezolizuma
  • 批准号：
    10273221
  • 项目类别：
  • 资助金额：
    $20.0万
  • 财政年份：
    2020
  • 负责人：
    LEONARD FREEDMAN
  • 依托单位：
    LEIDOS BIOMEDICAL RESEARCH, INC.
DCP - Pilot - Biomarker Reference Laboratory
  • 批准号：
    10282237
  • 项目类别：
  • 资助金额：
    $15.0万
  • 财政年份：
    2020
  • 负责人：
    LEONARD FREEDMAN
  • 依托单位：
    LEIDOS BIOMEDICAL RESEARCH, INC.
海外基金